Cargando…
Association between sodium-glucose cotransporter-2 inhibitors and incident atrial fibrillation/atrial flutter in heart failure patients with reduced ejection fraction: a meta-analysis of randomized controlled trials
Atrial fibrillation (AF) and atrial flutter (AFL) are associated with adverse outcomes in patients with heart failure and reduced ejection fraction (HFrEF). We investigated the effects of sodium-glucose cotransporter-2 inhibitors (SGLT2i) on the incidence of AF and/or AFL in HFrEF patients. PubMed a...
Autores principales: | Sfairopoulos, Dimitrios, Liu, Tong, Zhang, Nan, Tse, Gary, Bazoukis, George, Letsas, Konstantinos, Goudis, Christos, Milionis, Haralampos, Vrettos, Apostolos, Korantzopoulos, Panagiotis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289933/ https://www.ncbi.nlm.nih.gov/pubmed/36282460 http://dx.doi.org/10.1007/s10741-022-10281-3 |
Ejemplares similares
-
Inflammation and atrial fibrillation: A comprehensive review
por: Korantzopoulos, Panagiotis, et al.
Publicado: (2018) -
Association between routine biomarkers and atrial fibrillation in patients undergoing implantation of a dual‐chamber pacemaker
por: Kyrlas, Konstantinos, et al.
Publicado: (2020) -
Galectin‐3 and risk of atrial fibrillation: A systematic review and meta‐analysis
por: Gong, Mengqi, et al.
Publicado: (2020) -
Atrial Fibrillation: Mechanisms and Management
por: Liu, Tong, et al.
Publicado: (2019) -
Xanthine Oxidase and Uric Acid in Atrial Fibrillation
por: Korantzopoulos, Panagiotis, et al.
Publicado: (2012)